Insulet Corp (PODD) stock

PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3046% below fair value

$149.29−0.74 (-0.49%)

Close on Nov 12, 2026Market cap $10.35BP/E 24.3Yield –

Insulet price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Insulet's price to sales ratio was 3.5× on Nov 11, 2026, against 9.4× a year earlier. Over the last 5 years it ranged from 3.0× to 17.7×, with a median of 9.2×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	3.5×	−4.7
2025	Dec 31, 2025	8.2×	−1.1
2024	Dec 31, 2024	9.2×	−0.5
2023	Dec 29, 2023	9.7×	−6.7
2022	Dec 30, 2022	16.4×	−1.2
2021	Dec 31, 2021	17.7×	−1.7
2020	Dec 31, 2020	19.4×	+4.2
2019	Dec 31, 2019	15.2×	+6.4
2018	Dec 31, 2018	8.8×	−0.3
2017	Dec 29, 2017	9.2×	+3.0
2016	Dec 30, 2016	6.2×	−2.3
2015	Dec 31, 2015	8.5×	−0.5
2014	Dec 31, 2014	9.1×	+0.5
2013	Dec 31, 2013	8.6×	+3.5
2012	Dec 31, 2012	5.1×	−1.6
2011	Dec 30, 2011	6.7×	–